Caspase-6

Migration, Crosslink

📖

Caspase-6

active

wiki page Created: 2026-04-02T07:19:12 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-casp6-protein

📖 Wiki Page

protein1093 wordssynced 2026-04-02

Caspase-6

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Caspase-6</th>
</tr>
<tr> [@bhatt2022]
<td class="label">Gene</td> [@bhatt2012]
<td><a href="/genes/casp6">CASP6</a></td> [@bhatt2020]
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P55212" target="_blank">P55212</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td><a href="https://www.rcsb.org/structure/3OD5" target="_blank">3OD5</a>, <a href="https://www.rcsb.org/structure/4FXO" target="_blank">4FXO</a></td>
</tr>
<tr>
<td class="label">Mol.

...

Caspase-6

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Caspase-6</th>
</tr>
<tr> [@bhatt2022]
<td class="label">Gene</td> [@bhatt2012]
<td><a href="/genes/casp6">CASP6</a></td> [@bhatt2020]
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P55212" target="_blank">P55212</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td><a href="https://www.rcsb.org/structure/3OD5" target="_blank">3OD5</a>, <a href="https://www.rcsb.org/structure/4FXO" target="_blank">4FXO</a></td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>~34 kDa (proenzyme), p18+p11 (active)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm, nucleus, mitochondria</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Caspase family (C14 clan, executioner caspase)</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/alzheimers">Alzheimer's Disease</a>, <a href="/diseases/huntingtons">Huntington's Disease</a>, <a href="/diseases/als">ALS</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">Alzheimer Disease</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/huntington-disease" style="color:#ef9a9a">Huntington Disease</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">24 edges</a></td>
</tr>
</table>

Caspase-6

Overview

Caspase-6 is an executioner cysteine-aspartate protease encoded by the [CASP6](/genes/casp6) gene. It is synthesized as a 34 kDa inactive zymogen (procaspase-6) that requires proteolytic processing to generate the active p18/p11 heterodimer. Caspase-6 occupies a unique position among executioner caspases due to its substrate specificity for neurodegeneration-critical proteins: it cleaves [tau](/proteins/tau) at Asp421, generating neurotoxic [tau](/proteins/tau) fragments found in Alzheimer's disease tangles, and cleaves [huntingtin](/proteins/huntingtin-protein) at Asp586, producing the toxic N-terminal fragments essential for Huntington's disease pathogenesis.

Structure

Proenzyme Architecture

Procaspase-6 (293 amino acids) comprises:

Prodomain (residues 1-23): Short N-terminal peptide removed during activation. Unlike initiator caspases, caspase-6 has a short prodomain without CARD or DED motifs.

Large subunit (p18) (residues 24-179): Contains the catalytic cysteine (Cys163) in the conserved QACQG pentapeptide motif

Intersubunit linker (residues 180-193): Removed during activation; contains the processing site Asp193

Small subunit (p11) (residues 194-293): Completes the active site and contributes to substrate binding

Active Enzyme

The mature enzyme is a homodimer of p18/p11 heterodimers (p18₂p11₂):

Two active sites face the same direction in the dimer
Each active site is formed at the interface between p18 and p11 subunits
Crystal structures (PDB: 3OD5, 4FXO) reveal the typical caspase fold with a central β-sheet flanked by α-helices
Substrate specificity pocket accommodates VEID/VEHD sequences (P4-P1 positions)

Unique Structural Features

Caspase-6 has several distinguishing structural properties:

Self-activation capability: Unlike caspase-3/7, procaspase-6 can undergo intramolecular self-cleavage at Asp179, enabling activation without upstream caspases
Zinc inhibition site: An allosteric zinc-binding site (His121, Cys163, Cys263) allows physiological regulation by zinc ions
Conformational flexibility: The active-site loop (L2') adopts an extended conformation not seen in other executioner caspases, contributing to distinct substrate specificity

Substrate Specificity

Caspase-6 prefers the recognition sequence VEID↓X (Val-Glu-Ile-Asp):

Optimal P4: hydrophobic (Val, Leu)
P3: Glu (distinguishes from caspase-3 preference for Asp at P3)
P2: Ile or hydrophobic
P1: Asp (absolutely required)
This sequence differs from caspase-3 (DEVD) and caspase-7 (DEVD), conferring distinct substrate selectivity

Function and Signaling

Apoptotic Execution

In the classical apoptotic cascade:

Intrinsic pathway: Cytochrome c → apoptosome → [caspase-9](/genes/casp9) → [caspase-3](/genes/casp3) → caspase-6

Extrinsic pathway: Death receptors → [caspase-8](/genes/casp8) → caspase-6 (direct) or → caspase-3 → caspase-6

[Caspase-1](/genes/casp1) can directly activate caspase-6, linking inflammation to [apoptosis](/entities/apoptosis)

Feedback Amplification

Caspase-6 creates a positive feedback loop by cleaving and activating [caspase-8](/genes/casp8), which in turn activates more caspase-6. This caspase-6/caspase-8 amplification circuit is particularly active in [neurons](/entities/neurons) and contributes to the irreversibility of the apoptotic program.

Neuronal Substrate Cleavage

Tau cleavage (D421):

Caspase-6 cleaves tau at Asp421, removing the C-terminal 20 amino acids
Truncated tau (Tau-ΔC, 1-421) has:
Enhanced aggregation propensity (~3-fold faster fibril formation)
Increased toxicity to cultured neurons
Greater ability to seed [tau aggregation](/mechanisms/tau-propagation)
Reduced microtubule binding affinity
Caspase-6-cleaved tau is one of the earliest post-translational modifications detected in AD brains

[Huntingtin](/proteins/huntingtin) cleavage (D586):

Caspase-6 cleaves [huntingtin](/proteins/huntingtin-protein) at Asp586, generating:
N-terminal fragment (1-586) that is toxic when it contains expanded polyQ
The caspase-6 cleavage fragment is the predominant toxic species in HD models
YAC128 mice with D586A-resistant huntingtin are completely protected from neurodegeneration

Other neuronal substrates:

Lamin A/C: Nuclear envelope collapse
α-Tubulin: Microtubule destabilization and axonal transport failure
[Presenilin-1](/genes/psen1): Modulation of [γ-secretase](/entities/gamma-secretase) and [amyloid-β](/proteins/amyloid-beta-protein) production
VDAC1: Mitochondrial permeabilization
[DJ-1](/genes/park7): Oxidative stress response impairment

Non-Apoptotic Functions

Caspase-6 has important roles beyond cell death:

Axon pruning: Mediates selective axon degeneration during development via localized activation
Synaptic depression: Low-level caspase-6 activity at synapses participates in AMPA receptor internalization and long-term depression (LTD)
Inflammasome signaling: Activates the [NLRP3](/genes/nlrp3) inflammasome complex
B cell development: Required for normal B lymphocyte activation and differentiation

Role in Disease

Alzheimer's Disease Pathology

Active caspase-6 is intimately linked to [AD](/diseases/alzheimers-disease) pathology:

Immunohistochemistry reveals active caspase-6 in neuritic plaques, neuropil threads, and neurofibrillary tangles
Active caspase-6 is detected in mild cognitive impairment (MCI) cases before clinical AD diagnosis
Caspase-6-cleaved tau (TauC6 neoepitope) colocalizes with PHF-1 (phospho-tau) in tangles
Higher caspase-6 activity in hippocampal lysates predicts lower cognitive performance
Caspase-6 activation correlates with [APOE](/genes/apoe) ε4 carrier status

Huntington's Disease

Caspase-6 cleavage of mutant huntingtin at D586 is required for disease onset in mice
Active caspase-6 is elevated in presymptomatic and symptomatic HD striatum
Preventing caspase-6 cleavage of huntingtin is sufficient to prevent motor deficits, cognitive decline, and striatal atrophy in YAC128 mice
This has made caspase-6-resistant huntingtin a therapeutic strategy for HD

Protein-Protein Interactions

| Partner | Interaction Type | Consequence |
|---|---|---|
| [Tau](/proteins/tau) | Substrate (D421) | Toxic truncated tau |
| [Huntingtin](/proteins/huntingtin-protein) | Substrate (D586) | Toxic N-terminal fragments |
| [Caspase-8](/genes/casp8) | Substrate + activator | Feedback amplification |
| [Caspase-3](/genes/casp3) | Upstream activator | Apoptotic cascade |
| [Caspase-1](/genes/casp1) | Upstream activator | Inflammation-apoptosis link |
| Lamin A/C | Substrate | Nuclear breakdown |
| XIAP | Inhibitor | Negative regulation |
| Zinc (Zn²⁺) | Allosteric inhibitor | Physiological regulation |

Pathway & Interaction Diagram

Interactive diagram showing CASPASE-6's key relationships in the SciDEX knowledge graph (8 connections shown).

Mermaid diagram (expand to render)

External Links

[Caspase-6 at UniProt (P55212)](https://www.uniprot.org/uniprot/P55212)
[Caspase-6 at PDB (3OD5)](https://www.rcsb.org/structure/3OD5)
[Caspase-6 at Human Protein Atlas](https://www.proteinatlas.org/ENSG00000138794-CASP6)
[Caspase-6 at MEROPS (C14.005)](https://www.ebi.ac.uk/merops/cgi-bin/pepsum?id=C14.005)

References

[Bhatt et al., The activated form of caspase-6 is detected at the earliest stages of Alzheimer's disease neuropathology (2014) (2014)](https://doi.org/10.1186/1750-1326-9-2)

[Graham et al., Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin (2006) (2006)](https://doi.org/10.1016/j.cell.2006.06.026)

[LeBlanc et al., Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease (1999) (1999)](https://doi.org/10.1074/jbc.274.33.23426)

[Bhatt et al., Caspase-6-cleaved tau is relevant in Alzheimer's disease (2019) (2019)](https://doi.org/10.3233/JAD-181059)

[Bhatt et al., Protective caspase-6 self-cleavage prevents self-activation (2022) (2022)](https://doi.org/10.1016/j.str.2022.01.007)

[Bhatt et al., Active caspase-6 in the hippocampus is associated with lower episodic memory in non-demented elderly (2012) (2012)](https://doi.org/10.1111/j.1365-2990.2012.01325.x)

[Bhatt et al., Caspase-6 is a key regulator of Alzheimer's disease pathology (2020) (2020)](https://doi.org/10.1016/j.celrep.2020.107652)

📖 View canonical wiki page →

Related Entities

CASP6PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-casp6-protein
kg_node_id	CASP6PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-de5f66a00a43
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-casp6-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Caspase-6

Caspase-6

Caspase-6

Caspase-6

Overview

Structure

Proenzyme Architecture

Active Enzyme

Unique Structural Features

Substrate Specificity

Function and Signaling

Apoptotic Execution

Feedback Amplification

Neuronal Substrate Cleavage

Non-Apoptotic Functions

Role in Disease

Alzheimer's Disease Pathology

Huntington's Disease

Protein-Protein Interactions

Pathway & Interaction Diagram

See Also

External Links

References

💬 Discussion